Hazlett, Burt & Watson’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53K Buy
626
+1
+0.2% +$80 0.01% 457
2026
Q1
$53K Buy
625
+167
+36% +$12.6K 0.02% 438
2025
Q4
$31K Hold
458
0.01% 524
2025
Q3
$32K Hold
458
0.01% 489
2025
Q2
$34K Sell
458
-51
-10% -$3.4K 0.01% 427
2025
Q1
$32K Buy
509
+1
+0.2% +$62 0.01% 422
2024
Q4
$29K Sell
508
-105
-17% -$6.21K 0.01% 423
2024
Q3
$36K Hold
613
0.02% 390
2024
Q2
$33K Hold
613
0.02% 388
2024
Q1
$35K Buy
613
+18
+3% +$930 0.02% 376
2023
Q4
$29K Sell
595
-57
-9% -$2.72K 0.02% 377
2023
Q3
$33K Sell
652
-15
-2% -$794 0.02% 353
2023
Q2
$38K Buy
667
+10
+2% +$584 0.03% 339
2023
Q1
$40K Buy
657
+94
+17% +$5.74K 0.03% 308
2022
Q4
$33K Buy
563
+25
+5% +$1.58K 0.03% 321
2022
Q3
$31K Hold
538
0.03% 314
2022
Q2
$29K Buy
538
+1
+0.2% +$58 0.03% 330
2022
Q1
$31K Buy
+537
New +$27.4K 0.02% 339

Other funds holding CTVA

Hazlett, Burt & Watson's CTVA Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Corteva (CTVA) stake by 0.16% in Q2 2026, buying an estimated $80 and bringing the position to 626 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #457.

Hazlett, Burt & Watson first reported a position in CTVA in Q1 2022 and has held it in 18 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Hazlett, Burt & Watson held 626 shares of Corteva worth $53K as of Q2 2026.
  • Hazlett, Burt & Watson bought 1 Corteva share in Q2 2026, an estimated $80.
  • Corteva made up 0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #457 holding.
  • Hazlett, Burt & Watson first reported a position in Corteva in Q1 2022 and has held it in 18 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.